PDEX Pro Dex PE ratio, current and historical analysis
As of Feb 21, 2025, the Pro Dex stock's PE ratio is 15.69. This results from the current EPS of $2.04 and stock price of $32. The P/E ratio has a decrease of 40% from the past four quarters average of 26.2.
PDEX PE ratio history
The PE ratio of Pro Dex has averaged 16.41 over the last ten years. The current PE ratio of 15.69 is 4.4% below the historical average. Over the past ten years, PDEX's PE ratio was at its highest in the Dec 2015 quarter at 48.32, when the stock price was $2.42 and the EPS was $0.05. The lowest value was in the Mar 2017 quarter, when it reached 4.07 with a price of $4.6 and an EPS of $1.13.
Pro Dex PE ratio by year
Maximum annual increase: 258.61% in 2018
Maximum annual decrease: -82.45% in 2017
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | 32.2 | 233.68% | $19.64 | $0.61 |
| 2023 | 9.65 | -23.78% | $19.1 | $1.98 |
| 2022 | 12.66 | -32.48% | $15.95 | $1.26 |
| 2021 | 18.75 | 64.19% | $30.56 | $1.63 |
| 2020 | 11.42 | -12.89% | $17.82 | $1.56 |
| 2019 | 13.11 | -25.09% | $12.98 | $0.99 |
| 2018 | 17.5 | 258.61% | $6.65 | $0.38 |
| 2017 | 4.88 | -82.45% | $6.15 | $1.26 |
| 2016 | 27.8 | N/A | $5.56 | $0.2 |
| 2015 | N/A | N/A | $2.34 | -$0.09 |
| 2014 | N/A | N/A | $2.1 | -$0.14 |
| 2013 | N/A | N/A | $1.9 | -$0.54 |
| 2012 | N/A | N/A | $2.03 | -$0.27 |
| 2011 | 2.57 | N/A | $2.08 | $0.81 |
| 2010 | N/A | N/A | $1.89 | -$0.92 |
Pro Dex PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Dec 2024 | 22.92 | 19% | $46.75 | $2.04 |
| Sep 2024 | 19.26 | -40.19% | $29.85 | $1.55 |
| Jun 2024 | 32.2 | 6.13% | $19.64 | $0.61 |
| Mar 2024 | 30.34 | 47.21% | $17.6 | $0.58 |
| Dec 2023 | 20.61 | 94.25% | $17.52 | $0.85 |
| Sep 2023 | 10.61 | 9.95% | $15.7 | $1.48 |
| Jun 2023 | 9.65 | 26.47% | $19.1 | $1.98 |
| Mar 2023 | 7.63 | -12.7% | $16.41 | $2.15 |
| Dec 2022 | 8.74 | -35.88% | $15.9 | $1.82 |
| Sep 2022 | 13.63 | 7.66% | $17.72 | $1.3 |
| Jun 2022 | 12.66 | -24.19% | $15.95 | $1.26 |
| Mar 2022 | 16.7 | 2.14% | $16.53 | $0.99 |
| Dec 2021 | 16.35 | 3.15% | $23.21 | $1.42 |
| Sep 2021 | 15.85 | -15.47% | $25.67 | $1.62 |
| Jun 2021 | 18.75 | 37.06% | $30.56 | $1.63 |
PDEX average PE ratio chart
PDEX's current P/E ratio is below the 3, 5 and 10-year averages.
PDEX PE vs peers
Compared to its peer stocks TMO and DHR, PDEX's PE ratio stands lower. Pro Dex is presently trading at a lower PE ratio (15.69) than its peer group average of 35.38.
| Stock name | PE ratio | Market cap |
|---|---|---|
| PDEX Pro Dex Inc | 15.69 | $104.35M |
| MDT Medtronic plc | 27.34 | $115.33B |
| TMO Thermo Fisher Scientific Inc | 32.12 | $200.91B |
| ALGN Align Technology Inc | 32.5 | $14.22B |
| DHR Danaher Corp | 39.44 | $150.25B |
| TDG TransDigm Group INC | 45.49 | $72.36B |
| RVP Retractable Technologies Inc | N/A | $25.33M |
| XRAY DENTSPLY SIRONA Inc | N/A | $3.73B |
Frequently asked questions
What is Pro Dex's PE ratio?
The price to earnings ratio for PDEX stock as of Feb 21, 2025, stands at 15.69.
What is the 3-year average PE ratio for Pro Dex (PDEX)?
The 3-year average PE ratio for PDEX stock is 17.08.
What is the 5-year average PE ratio for Pro Dex (PDEX)?
The 5-year average PE ratio for PDEX stock is 16.57.
What is the highest PE ratio for PDEX?
In the last ten years, the Dec 2015 quarter recorded the highest quarterly PE ratio at 48.32.
How does the current PE ratio for PDEX compare to its historical average?
PDEX's price to earnings ratio is currently 4.4% below its 10-year historical average.
How is PDEX's PE ratio calculated (Pro Dex PE ratio formula)?
To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Feb 21, 2025), Pro Dex's stock price is $32. The earnings per share for the trailing twelve months (TTM) ending Dec 2024 is $2.04. Therefore, Pro Dex's P/E ratio for today is 15.69. PE RATIO(15.69) = STOCK PRICE($32) / TTM EPS($2.04)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.